Amsurg Corp (AMSG) 55.56 $AMSG
Amsurg (AMSG) Highlighted As Strong And Under The Radar Stock Of The Day
at The Street - Fri Feb 06, 8:48AM CST
Trade-Ideas LLC identified Amsurg (AMSG) as a strong and under the radar candidate
AMSG: 55.56 (+0.48)
AmSurg: Two Great Businesses In One Company
Real Estater - at Seeking Alpha - Mon Feb 02, 2:08PM CST
AMSG: 55.56 (+0.48)
Economy And ObamaCare Lift Walk-In Surgery At AmSurg
at Investor's Business Daily - Mon Feb 02, 1:52PM CST
Most medical stocks are considered defensive plays, which means that they're a good place to put your money during downturns. The reason is simple: People need medical care regardless of the economy, so medical stocks won't suffer when the economy is...
AMSG: 55.56 (+0.48), AFAM: 30.88 (+0.37), SCAI: 32.88 (+0.12), HLS: 45.01 (+0.30), MD: 71.32 (-0.06)
Team Health Holdings: A Well-Run Company With Strong Growth Prospects
Real Estater - at Seeking Alpha - Fri Jan 30, 12:24AM CST
AMSG: 55.56 (+0.48), EVHC: 36.20 (-0.09), TMH: 59.69 (-0.19), MD: 71.32 (-0.06)
Quest Diagnostics Q4 Earnings, Revenues Beat; Grow Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 29, 2:37PM CST
Quest Diagnostics' (DGX) fourth-quarter 2014 adjusted earnings per share (EPS) from continuing operations of $1.08 exceeded the Zacks Consensus Estimate by 3 cents.
AMSG: 55.56 (+0.48), RDNT: 8.66 (-0.11), DGX: 71.68 (+0.03), AMED: 28.62 (+0.16)
Presbia Puts Your Reading Glasses In Your Eyeball
IPO Candy - at Seeking Alpha - Thu Jan 29, 8:02AM CST
AMSG: 55.56 (+0.48), EYES: 8.95 (-0.19), LMNS: 10.80 (+0.57), LENS: 6.00 (-0.67)
AmSurg Corp. Sets Earnings Release and Conference Call Dates for Fourth Quarter and Year-End 2014 Results
Business Wire - Wed Jan 28, 10:00AM CST
AmSurg Corp. (Nasdaq: AMSG) today announced it will release its fourth quarter and year-end 2014 financial results on Wednesday, February 25, 2015, after the market closes. The Company will also host a conference call at 9:00 a.m. Eastern Time on Thursday, February 26, 2015. The live broadcast of AmSurg Corp.'s quarterly conference call will be available on-line by going to http://www.amsurg.com and clicking on the link to Investor Relations. The on-line replay will follow shortly after the call and continue for 30 days.
AMSG: 55.56 (+0.48)
Strong And Under The Radar Today: Amsurg (AMSG)
at The Street - Fri Jan 23, 8:45AM CST
Trade-Ideas LLC identified Amsurg (AMSG) as a strong and under the radar candidate
AMSG: 55.56 (+0.48)
Upgrade Alert for Amsurg (AMSG)
Comtex SmarTrend(R) - Fri Jan 23, 6:58AM CST
Amsurg (NASDAQ:AMSG) was upgraded from Neutral to Overweight at Piper Jaffray today. The stock closed yesterday at $55.03 on volume of 441,000 shares, above average daily volume of 414,000. Over the past year, Amsurg has traded in a range of $40.00 to $55.65 and closed yesterday at $55.03, 38% above that low. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has advanced 0.3%.
AMSG: 55.56 (+0.48)
AmSurg's Physician Services Division, Sheridan, Completes Acquisition of Radisphere
Business Wire - Wed Jan 21, 11:51AM CST
Sheridan, the Physician Services division of AmSurg Corp. (NASDAQ: AMSG), is expanding its radiology services business through the acquisition of Radisphere, a group of over 100 radiologists who read more than one million studies per year.
AMSG: 55.56 (+0.48)
AmSurg reports senior notes due 2022 exchange offer
M2 - Mon Jan 19, 7:32AM CST
Ambulatory surgery centre company AmSurg (NASDAQ:AMSG) disclosed on Friday an offer to exchange up to USD1.1bn aggregate principal amount of its 5.625% senior notes due 2022 that have been registered under the Securities Act of 1933, as amended (exchange notes).
AMSG: 55.56 (+0.48)
AmSurg Corp. Announces Launch of Exchange Offer for 5.625% Senior Notes Due 2022
Business Wire - Fri Jan 16, 4:06PM CST
AmSurg Corp. (the "Company"
(NASDAQ: AMSG) today announced that it has launched an offer to exchange up to $1.1 billion aggregate principal amount of its 5.625% Senior Notes due 2022, which have been registered under the Securities Act of 1933, as amended (the "Act" (the "exchange notes" for any or all of its $1.1 billion aggregate principal amount of 5.625% Senior Notes due 2022, which are not registered under the Act (the "private notes" . The exchange offer will expire at 5:00 p.m. (New York City time) on February 18, 2015, unless extended by the Company. Valid tenders of the private notes must be made, and may be withdrawn at any time, before the exchange offer expires.
AMSG: 55.56 (+0.48)
AmSurg's Physician Services Division, Sheridan, Completes Agreement with Anesthesia Group Serving AmSurg Surgery Center
Business Wire - Tue Jan 13, 5:12PM CST
Sheridan, the Physician Services division of AmSurg Corp. (NASDAQ: AMSG), today announced the affiliation of Ambulatory Anesthesia Care, P.C., an anesthesia group practice serving ambulatory facilities in Mountainside and Edison, New Jersey.
AMSG: 55.56 (+0.48)
AmSurg Corp. to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Fri Jan 09, 5:16PM CST
AmSurg Corp. (NASDAQ: AMSG) today announced that it will participate in the 33rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015, in San Francisco, California. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company's web site starting at 8:00 a.m. Pacific Time / 10:00 a.m. Central Time. Christopher A. Holden, President and Chief Executive Officer, and Claire M. Gulmi, Executive Vice President and Chief Financial Officer, will be speaking at the conference.
AMSG: 55.56 (+0.48), JPM: 59.67 (+0.10)
Amsurg (AMSG) Showing Signs Of Being Strong And Under The Radar
at The Street - Fri Jan 02, 8:50AM CST
Trade-Ideas LLC identified Amsurg (AMSG) as a strong and under the radar candidate
AMSG: 55.56 (+0.48)
AmSurg Banks on Sheridan Buy to Boost Ambulatory Services - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 29, 1:30PM CST
On Dec 28, we issued an updated research report on AmSurg Corporation (AMSG).
CHE: 107.38 (-0.43), AMSG: 55.56 (+0.48), ADUS: 21.57 (+0.18), AMED: 28.62 (+0.16)
Barbarian At The Gate: Amsurg (AMSG)
at The Street - Thu Dec 18, 2:12PM CST
Trade-Ideas LLC identified Amsurg (AMSG) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
AMSG: 55.56 (+0.48)
United States Outpatient Care Centers Industry Analytics 2014-2021 - Extensive Financial Benchmarks, Metrics and Revenue Forecasts - Market to reach $169.3 billion by 2021
M2 - Mon Dec 15, 8:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/wxgmv7/outpatient_care) has announced the addition of Plunkett Research Ltd's new report "Outpatient Care Centers Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Outpatient Care Centers Industry (U.S.) to reach $169.3 billion by 2021 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked - Advanzeon Solutions Inc - AmSurg Corp - DaVita Healthcare Partners Inc - Dynacq Healthcare Inc - Fresenius Medical Care Holdings Inc - Graymark Healthcare Inc - IntegraMed America Inc - LCA-Vision Inc - United Surgical Partners International Inc For more information visit http://www.researchandmarkets.com/research/wx...tient_care Source: Plunkett Research Ltd
LCAV: 5.37 (unch), AMSG: 55.56 (+0.48)
Insider Trading Alert - HFWA, AMSG And MHR Traded By Insiders
at The Street - Fri Dec 05, 10:00AM CST
Stocks with insider trader activity include HFWA, AMSG and MHR
AMSG: 55.56 (+0.48), MHR: 2.62 (+0.11), HFWA: 16.48 (-0.12)
Amsurg (AMSG) Highlighted As Strong And Under The Radar Stock Of The Day
at The Street - Fri Feb 06, 8:48AM CST
Trade-Ideas LLC identified Amsurg (AMSG) as a strong and under the radar candidate
AMSG: 55.56 (+0.48)
AmSurg: Two Great Businesses In One Company
Real Estater - at Seeking Alpha - Mon Feb 02, 2:08PM CST
AMSG: 55.56 (+0.48)
Economy And ObamaCare Lift Walk-In Surgery At AmSurg
at Investor's Business Daily - Mon Feb 02, 1:52PM CST
Most medical stocks are considered defensive plays, which means that they're a good place to put your money during downturns. The reason is simple: People need medical care regardless of the economy, so medical stocks won't suffer when the economy is...
AMSG: 55.56 (+0.48), AFAM: 30.88 (+0.37), SCAI: 32.88 (+0.12), HLS: 45.01 (+0.30), MD: 71.32 (-0.06)
Team Health Holdings: A Well-Run Company With Strong Growth Prospects
Real Estater - at Seeking Alpha - Fri Jan 30, 12:24AM CST
AMSG: 55.56 (+0.48), EVHC: 36.20 (-0.09), TMH: 59.69 (-0.19), MD: 71.32 (-0.06)
Quest Diagnostics Q4 Earnings, Revenues Beat; Grow Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 29, 2:37PM CST
Quest Diagnostics' (DGX) fourth-quarter 2014 adjusted earnings per share (EPS) from continuing operations of $1.08 exceeded the Zacks Consensus Estimate by 3 cents.
AMSG: 55.56 (+0.48), RDNT: 8.66 (-0.11), DGX: 71.68 (+0.03), AMED: 28.62 (+0.16)
Presbia Puts Your Reading Glasses In Your Eyeball
IPO Candy - at Seeking Alpha - Thu Jan 29, 8:02AM CST
AMSG: 55.56 (+0.48), EYES: 8.95 (-0.19), LMNS: 10.80 (+0.57), LENS: 6.00 (-0.67)
AmSurg Corp. Sets Earnings Release and Conference Call Dates for Fourth Quarter and Year-End 2014 Results
Business Wire - Wed Jan 28, 10:00AM CST
AmSurg Corp. (Nasdaq: AMSG) today announced it will release its fourth quarter and year-end 2014 financial results on Wednesday, February 25, 2015, after the market closes. The Company will also host a conference call at 9:00 a.m. Eastern Time on Thursday, February 26, 2015. The live broadcast of AmSurg Corp.'s quarterly conference call will be available on-line by going to http://www.amsurg.com and clicking on the link to Investor Relations. The on-line replay will follow shortly after the call and continue for 30 days.
AMSG: 55.56 (+0.48)
Strong And Under The Radar Today: Amsurg (AMSG)
at The Street - Fri Jan 23, 8:45AM CST
Trade-Ideas LLC identified Amsurg (AMSG) as a strong and under the radar candidate
AMSG: 55.56 (+0.48)
Upgrade Alert for Amsurg (AMSG)
Comtex SmarTrend(R) - Fri Jan 23, 6:58AM CST
Amsurg (NASDAQ:AMSG) was upgraded from Neutral to Overweight at Piper Jaffray today. The stock closed yesterday at $55.03 on volume of 441,000 shares, above average daily volume of 414,000. Over the past year, Amsurg has traded in a range of $40.00 to $55.65 and closed yesterday at $55.03, 38% above that low. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has advanced 0.3%.
AMSG: 55.56 (+0.48)
AmSurg's Physician Services Division, Sheridan, Completes Acquisition of Radisphere
Business Wire - Wed Jan 21, 11:51AM CST
Sheridan, the Physician Services division of AmSurg Corp. (NASDAQ: AMSG), is expanding its radiology services business through the acquisition of Radisphere, a group of over 100 radiologists who read more than one million studies per year.
AMSG: 55.56 (+0.48)
AmSurg reports senior notes due 2022 exchange offer
M2 - Mon Jan 19, 7:32AM CST
Ambulatory surgery centre company AmSurg (NASDAQ:AMSG) disclosed on Friday an offer to exchange up to USD1.1bn aggregate principal amount of its 5.625% senior notes due 2022 that have been registered under the Securities Act of 1933, as amended (exchange notes).
AMSG: 55.56 (+0.48)
AmSurg Corp. Announces Launch of Exchange Offer for 5.625% Senior Notes Due 2022
Business Wire - Fri Jan 16, 4:06PM CST
AmSurg Corp. (the "Company"
(NASDAQ: AMSG) today announced that it has launched an offer to exchange up to $1.1 billion aggregate principal amount of its 5.625% Senior Notes due 2022, which have been registered under the Securities Act of 1933, as amended (the "Act" (the "exchange notes" for any or all of its $1.1 billion aggregate principal amount of 5.625% Senior Notes due 2022, which are not registered under the Act (the "private notes" . The exchange offer will expire at 5:00 p.m. (New York City time) on February 18, 2015, unless extended by the Company. Valid tenders of the private notes must be made, and may be withdrawn at any time, before the exchange offer expires. AMSG: 55.56 (+0.48)
AmSurg's Physician Services Division, Sheridan, Completes Agreement with Anesthesia Group Serving AmSurg Surgery Center
Business Wire - Tue Jan 13, 5:12PM CST
Sheridan, the Physician Services division of AmSurg Corp. (NASDAQ: AMSG), today announced the affiliation of Ambulatory Anesthesia Care, P.C., an anesthesia group practice serving ambulatory facilities in Mountainside and Edison, New Jersey.
AMSG: 55.56 (+0.48)
AmSurg Corp. to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Business Wire - Fri Jan 09, 5:16PM CST
AmSurg Corp. (NASDAQ: AMSG) today announced that it will participate in the 33rd Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2015, in San Francisco, California. In connection with the conference, there will be an on-line simulcast and a replay of the presentation available at the Company's web site starting at 8:00 a.m. Pacific Time / 10:00 a.m. Central Time. Christopher A. Holden, President and Chief Executive Officer, and Claire M. Gulmi, Executive Vice President and Chief Financial Officer, will be speaking at the conference.
AMSG: 55.56 (+0.48), JPM: 59.67 (+0.10)
Amsurg (AMSG) Showing Signs Of Being Strong And Under The Radar
at The Street - Fri Jan 02, 8:50AM CST
Trade-Ideas LLC identified Amsurg (AMSG) as a strong and under the radar candidate
AMSG: 55.56 (+0.48)
AmSurg Banks on Sheridan Buy to Boost Ambulatory Services - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Dec 29, 1:30PM CST
On Dec 28, we issued an updated research report on AmSurg Corporation (AMSG).
CHE: 107.38 (-0.43), AMSG: 55.56 (+0.48), ADUS: 21.57 (+0.18), AMED: 28.62 (+0.16)
Barbarian At The Gate: Amsurg (AMSG)
at The Street - Thu Dec 18, 2:12PM CST
Trade-Ideas LLC identified Amsurg (AMSG) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
AMSG: 55.56 (+0.48)
United States Outpatient Care Centers Industry Analytics 2014-2021 - Extensive Financial Benchmarks, Metrics and Revenue Forecasts - Market to reach $169.3 billion by 2021
M2 - Mon Dec 15, 8:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/wxgmv7/outpatient_care) has announced the addition of Plunkett Research Ltd's new report "Outpatient Care Centers Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021" to their offering. Outpatient Care Centers Industry (U.S.) to reach $169.3 billion by 2021 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless hours of research. This Report Features: 1. Historical data 2. Revenue forecasts, growth rates and CAGR 3. Operating ratios 4. Complete data for benchmarking a company to its industry and to specific leading companies 5. Benchmarking this industry to all U.S. industries 6. Deep profiles and financial histories/operating ratios for up to ten top U.S.-based companies Designed to benefit: - Analysis and Financial Modeling - Investment Professionals - Lenders - M&A Advisors - Appraisers - Consultants Key Data: Industry Summary - Revenues historical through 2013 - Revenues projected through 2021 - Employee Count 2007-2013 - Annual Growth Rate 2013 - CAGR 2006 through 2013 - CAGR 2014 through 2021 - Top U.S. Companies Employment and Establishments - Number of Firms 2007-2013 - Number of Establishments 2007-2013 - Employees, 2007-2013 - Average Annual Sales per Firm & per Establishment 2007-2013 - Sales per Employee Average Annual Operating Ratios - Revenue Compared to All Industries - Expenses Compared to All Industries - Profits & Income Taxes Compared to All Industries Benchmarks This Industry Compared to All Industries - Comparison of Revenues, Profits and Taxes to All Industries Industry Results, Publicly-Held Companies (U.S.), Average for all Companies - Industry Income Statement, Balance Sheet, Cash Flow Statement, 2008-2013 Top Companies Profiled & Ranked - Advanzeon Solutions Inc - AmSurg Corp - DaVita Healthcare Partners Inc - Dynacq Healthcare Inc - Fresenius Medical Care Holdings Inc - Graymark Healthcare Inc - IntegraMed America Inc - LCA-Vision Inc - United Surgical Partners International Inc For more information visit http://www.researchandmarkets.com/research/wx...tient_care Source: Plunkett Research Ltd
LCAV: 5.37 (unch), AMSG: 55.56 (+0.48)
Insider Trading Alert - HFWA, AMSG And MHR Traded By Insiders
at The Street - Fri Dec 05, 10:00AM CST
Stocks with insider trader activity include HFWA, AMSG and MHR
AMSG: 55.56 (+0.48), MHR: 2.62 (+0.11), HFWA: 16.48 (-0.12)
